Specifically, when comparing age- and body mass index (BMI)-matched SARS-CoV-2-infected patients 3-months post-infection with never-infected control patients, they found a significantly higher level of serum osteoprotegerin (OPG), a bone remodeling regulator, in the infected patients [33]. This evidence concerns the gene TNFRSF11B and infection.